About Advanced Gastroenterology
Clinical Trials at Advanced Gastroenterology
During the past decade, Advanced Gastroenterology conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on
average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Advanced Gastroenterology" #1 sponsor was "Shire" with 5 trials, followed by "Celgene" with 3 trials
sponsored, "Adare Pharmaceuticals, Inc." with 1 trials sponsored, "Crestone, Inc" with 1 trials sponsored and "Eli Lilly and Company"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced Gastroenterology"
#1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Advanced Gastroenterology
According to Clinical.Site data, the most researched conditions in "Advanced Gastroenterology" are
"Crohn's Disease" (4 trials), "Crohn Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Colorectal Cancer" (2 trials) and "Adenoma" (1 trials). Many other conditions were trialed in "Advanced Gastroenterology" in a lesser frequency.
Clinical Trials Intervention Types at Advanced Gastroenterology
Most popular intervention types in "Advanced Gastroenterology" are "Drug" (11 trials), "Other" (6 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Ontamalimab" (4 trials), "Ozanimod" (3 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Advanced Gastroenterology
The vast majority of trials in "Advanced Gastroenterology" are
14 trials for "All" genders.
Clinical Trials Status at Advanced Gastroenterology
Currently, there are NaN active trials in "Advanced Gastroenterology".
undefined are not yet recruiting,
5 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Advanced Gastroenterology,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Advanced Gastroenterology, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".